About StageBio
StageBio is a company based in Mount Jackson (United States) founded in 2001. StageBio has completed 1 acquisition, including TPL Path Labs. StageBio offers products and services including Lab Services, Pathology Services, Biorepository Services, and Consulting Services. StageBio operates in a competitive market with competitors including Pulse Medical Imaging Technology, Asterand Bioscience, Radiomics, Keen Eye and Numira, among others.
- Headquarter Mount Jackson, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Hsrl Holdings Llc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of StageBio
StageBio offers a comprehensive portfolio of products and services, including Lab Services, Pathology Services, Biorepository Services, and Consulting Services.
Provides testing for preclinical and clinical research programs.
Offers analysis of tissue samples for biopharmaceutical applications.
Manages specimen archiving and secure storage solutions.
Delivers expert advice on pathology and research needs.
People of StageBio
Unlock access to complete
Funding Insights of StageBio
Investors in StageBio
StageBio has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Ampersand Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Ampersand Capital Partners is focused on investments in healthcare and life sciences.
|
Locked | Locked | Locked |
Investor details for StageBio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by StageBio
StageBio has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include TPL Path Labs.
Investment portfolio details for StageBio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Diagnostic pathology services are offered by a standalone laboratory.
|
Locked | Locked | 2008 | Locked |
Complete acquisition details for StageBio
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - StageBio
Detailed financials for StageBio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Stagebio Comparisons
Peer comparison for StageBio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of StageBio
StageBio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pulse Medical Imaging Technology, Asterand Bioscience, Radiomics, Keen Eye and Numira, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cardiac imaging services are offered by CRO in Shanghai.
|
|
| Locked | Locked | Locked |
Human tissue solutions for drug discovery research are supplied globally.
|
|
| Locked | Locked | Locked |
Provider of clinical trials support & software services for medical devices manufacturers
|
|
| Locked | Locked | Locked |
Manufacturer of drug development services for image analysis
|
|
| Locked | Locked | Locked |
Numira is a specialty preclinical CRO specializing in microCT imaging, image analysis, histology, and 3D cancer cell profiling.
|
Detailed competitors of StageBio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Stagebio
Complete news archive for StageBio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about StageBio
StageBio was founded in 2001 and raised its 1st funding round 17 years after it was founded.
StageBio is headquartered in Mount Jackson, United States. It is registered at Mount Jackson, Virginia, United States.
StageBio was founded in 2001 and is based in Mount Jackson, United States. Preclinical pathology services are offered by the company within the biotechnology and pharmaceutical sectors. Operations focus on histopathological analysis, toxicologic pathology, and related support for drug discovery and safety assessment. Expertise is applied to nonclinical studies, with services extending to digital pathology and consulting for global clients in the life sciences industry.
StageBio's top competitors include Asterand Bioscience, Pulse Medical Imaging Technology and Radiomics.
StageBio offers Lab Services, Pathology Services, Biorepository Services, and Consulting Services.
StageBio has made 1 acquisition, including TPL Path Labs.
StageBio has 1 investor. Key investors include Ampersand Capital Partners.